Anicom Holdings, Inc. ( (JP:8715) ) has provided an announcement.
Anicom Holdings, Inc. reported its monthly management parameters for March 2025, highlighting growth in net premiums, policies in force, and the number of PARM hospitals, which are key to its regenerative medicine business. The company’s focus on innovation and prevention in pet care is evident through its increasing number of patents and expansion of gut microbiota testing, positioning it as a leader in the BioInsurTech sector.
More about Anicom Holdings, Inc.
Anicom Holdings, Inc. operates in the pet insurance industry, focusing on providing insurance services for pets. The company is also involved in new business initiatives aimed at becoming a prevention-oriented company, leveraging big data and regenerative medicine to prevent injuries and illnesses in animals.
Average Trading Volume: 547,656
Technical Sentiment Signal: Buy
Current Market Cap: Yen46.58B
For an in-depth examination of 8715 stock, go to TipRanks’ Stock Analysis page.